-
www.uspreventiveservicestaskforce.org/uspstf/document/modeling-study/colorectal-cancer-screening-june-2016
June 15, 2016 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
archived
Modeling Study
Colorectal Cancer: Screening
June 15, 2016
Recommendations made by the USPSTF are independent of the U.S. government. They should not be construe…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-218-osteoporosis-fracture-prevention-evidence-summary.pdf
April 01, 2019 - CER 218 Evidence Summary: Long-Term Drug Therapy and Drug Holidays for Osteoporosis Fracture Prevention: A Systematic Review
Purpose of Review
To summarize the effects of long-term osteoporosis
drug treatment and of osteoporosis drug treatment
discontinuation and holidays.
Key Messages
• Evidence on the effects …
-
www.ahrq.gov/sites/default/files/wysiwyg/patient-safety/reports/issue-briefs/diagnostic-safety-transitions-care.pdf
June 01, 2023 - Diagnostic Safety Across Transitions of Care Throughout the Healthcare System: Current State and a Call to Action
PATIENT
SAFETY
e
Issue Brief 11
Diagnostic Safety Across Transitions of
Care Throughout the Healthcare System:
Current State and a Call to Action
This page intentionally left blank.
e
Issue …
-
digital.ahrq.gov/sites/default/files/docs/page/09-0069-EF_1.pdf
June 01, 2009 - Clinical Decision Support Systems: State of the Art
Clinical Decision Support Systems:
State of the Art
Prepared for:
Agency for Healthcare Research and Quality
U.S. Department of Health and Human Services
540 Gaither Road
Rockville, MD 20850…
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/T6Tquunynv3tWM65BFash2
October 01, 2015 - Behavioral and Pharmacotherapy Interventions for Tobacco Smoking
Cessation in Adults, Including Pregnant Women: U.S. Preventive
Services Task Force Recommendation Statement
Albert L. Siu, MD, MSPH, for the U.S. Preventive Services Task Force*
Description: Update of the 2009 U.S. Preventive Services Task
Force (USPSTF)…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/surveillance-report-2-nonopioid-pharm-chronic-pain.pdf
April 01, 2022 - Systematic Review on Nonopioid Pharmacologic Treatments for Chronic Pain: Surveillance Report 2
Systematic Review on Nonopioid
Pharmacologic Treatments for Chronic
Pain: Surveillance Report 2
Literature Update Period: October 2021 through December 2021
Background and Purpose
This is the second update for the 20…
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/impaired-visual-acuity-in-older-adults-screening-2016
March 01, 2016 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
archived
Evidence Summary
Impaired Visual Acuity in Older Adults: Screening
March 01, 2016
Recommendations made by the USPSTF are independent of the U.S. government. They…
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/2kM7LY6ccceVo8bmdUXhYm
September 01, 2002 - Screening for Postmenopausal Osteoporosis: A Summary of the Evidence
Epidemiology
Half of all postmenopausal women will have an
osteoporosis-related fracture during their lives,
including one-quarter who will develop a vertebral
deformity1 and 15% who will suffer a hip fracture.2
Hip fractures are associated with h…
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/cED9Pf3PNUHRUptzXQza-n
April 01, 2016 - Radiation-Induced Breast Cancer Incidence and Mortality From Digital
Mammography Screening
A Modeling Study
Diana L. Miglioretti, PhD; Jane Lange, PhD; Jeroen J. van den Broek, MSc; Christoph I. Lee, MD, MSHS;
Nicolien T. van Ravesteyn, PhD; Dominique Ritley, MPH; Karla Kerlikowske, MD; Joshua J. Fenton, MD, MPH;
Joy M…
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary48/suicide-risk-screening-2004
May 15, 2004 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
archived
Final Evidence Summary
Suicide Risk: Screening
May 15, 2004
Recommendations made by the USPSTF are independent of the U.S. government. They should not be const…
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/khUSqr94jqWPErt9ZRnQ95
October 01, 2009 - C-Reactive Protein as a Risk Factor for Coronary Heart Disease: A Systematic Review and Meta-analyses for the U.S. Preventive Services Task Force
C-Reactive Protein as a Risk Factor for Coronary Heart Disease:
A Systematic Review and Meta-analyses for the U.S. Preventive
Services Task Force
David I. Buckley, MD, MPH;…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/wireless-motility-capsule_executive.pdf
May 01, 2013 - 1
Comparative Effectiveness Review
Number 110
Wireless Motililty Capsule Versus Other
Diagnostic Technologies for Evaluating
Gastroparesis and Constipation: A
Comparative Effectiveness Review
Executive Summary
Gastroparesis
Definition and Prevalence
Gastroparesis is a condition in which
patients experience …
-
digital.ahrq.gov/sites/default/files/docs/citation/k08hs018582-lafleur-final-report-2015.pdf
January 01, 2015 - Knowledge Engineering for Decision Support in Osteoporosis - Final Report
1
Knowledge engineering for decision support in osteoporosis
Grant closeout final report
Principal Investigator: Joanne
LaFleur, PharmD, MSPH
Assistant Professor
University of Utah College of Pharmacy
T…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoporosis-bone-fracture_executive.pdf
March 01, 2012 - 1
Comparative Effectiveness Review
Number 53
Treatment To Prevent Fractures in Men
and Women With Low Bone Density or
Osteoporosis: Update of a 2007 Report
Executive Summary
Background
Osteoporosis is a systemic skeletal disease
characterized by decreasing bone mass and
microarchitectural deterioration of bo…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cystic-fibrosis-hgh_executive.pdf
October 01, 2010 - Layout 1
Background
Cystic fibrosis (CF) is the second most
common life-shortening, childhood-onset
genetic disease in the United States,
affecting approximately 30,000 people in
the Nation. The gene responsible for CF
encodes the cystic fibrosis transmembrane
regulator (CFTR) protein, which regulates
sodium and chl…
-
www.ahrq.gov/sites/default/files/wysiwyg/ncepcr/tools/PCMH/pcpf-module-15-presenting-data.pdf
September 01, 2015 - M15-3
Describing Your Methods
When preparing reports, be sure to include a description of the methodology
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs-IV-rapid-response-deprescribing.pdf
February 01, 2024 - search filters to identify articles on deprescribing in Medline and Embase | BMC
Medical Research Methodology
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patientsafetyculture/nursing-home/2016/nhsurv16-pt1.pdf
January 01, 2016 - In cases in which a sample was drawn, no data were
obtained to determine the methodology used to draw
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review55/genital-herpes-screening-2005
March 15, 2005 - Type specific antibodies to HSV1 and HSV2: review of methodology. Herpes 1998;5:33-8.
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/ZzZp7_aoJn73k9z25w_-qr
March 01, 2005 - Type specific antibodies to HSV1 and
HSV2: review of methodology. Herpes. 1998;5:33–38.
11.